 Mari Davidson
Concepts (124)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meiosis | 15 | 2024 | 64 | 2.240 |
Why?
| | Schizosaccharomyces | 16 | 2024 | 57 | 2.160 |
Why?
| | Recombination, Genetic | 12 | 2024 | 108 | 1.840 |
Why?
| | Schizosaccharomyces pombe Proteins | 12 | 2024 | 40 | 1.340 |
Why?
| | DNA | 5 | 2013 | 543 | 0.730 |
Why?
| | Phosphoproteins | 4 | 2013 | 111 | 0.480 |
Why?
| | Evolution, Molecular | 2 | 2012 | 97 | 0.470 |
Why?
| | RNA, Fungal | 2 | 2013 | 21 | 0.420 |
Why?
| | Homologous Recombination | 4 | 2022 | 40 | 0.410 |
Why?
| | Histone Code | 1 | 2010 | 30 | 0.350 |
Why?
| | Gene Expression Regulation, Fungal | 2 | 2013 | 51 | 0.340 |
Why?
| | Chromosomes, Fungal | 3 | 2008 | 13 | 0.340 |
Why?
| | MAP Kinase Signaling System | 2 | 2013 | 118 | 0.330 |
Why?
| | Activating Transcription Factor 1 | 4 | 2013 | 22 | 0.330 |
Why?
| | Chromatin Assembly and Disassembly | 2 | 2019 | 23 | 0.320 |
Why?
| | Gene Library | 1 | 2008 | 42 | 0.310 |
Why?
| | Plasmids | 1 | 2008 | 164 | 0.300 |
Why?
| | Chromatin | 2 | 2008 | 138 | 0.300 |
Why?
| | Alleles | 3 | 2019 | 253 | 0.290 |
Why?
| | Nucleotide Motifs | 2 | 2019 | 23 | 0.270 |
Why?
| | Base Pairing | 2 | 2019 | 27 | 0.270 |
Why?
| | Chromosome Segregation | 2 | 2010 | 12 | 0.260 |
Why?
| | 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2004 | 6 | 0.240 |
Why?
| | Mutagenesis, Insertional | 1 | 2004 | 24 | 0.240 |
Why?
| | DNA, Fungal | 4 | 2024 | 43 | 0.230 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 51 | 0.230 |
Why?
| | Mutation Rate | 2 | 2019 | 36 | 0.200 |
Why?
| | Vincristine | 1 | 2022 | 85 | 0.200 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 84 | 0.190 |
Why?
| | Mitosis | 3 | 2022 | 88 | 0.180 |
Why?
| | Base Sequence | 4 | 2022 | 653 | 0.180 |
Why?
| | Models, Genetic | 3 | 2011 | 174 | 0.170 |
Why?
| | Gene Targeting | 2 | 2019 | 31 | 0.150 |
Why?
| | Mutation | 5 | 2019 | 1288 | 0.140 |
Why?
| | Apoptosis | 1 | 2022 | 1093 | 0.140 |
Why?
| | Peptide Termination Factors | 1 | 2014 | 2 | 0.120 |
Why?
| | RNA, Transfer | 1 | 2014 | 15 | 0.120 |
Why?
| | Codon, Nonsense | 1 | 2014 | 26 | 0.120 |
Why?
| | Genetic Vectors | 2 | 2019 | 126 | 0.120 |
Why?
| | Histones | 2 | 2018 | 296 | 0.110 |
Why?
| | RNA Stability | 1 | 2013 | 24 | 0.110 |
Why?
| | Protein Biosynthesis | 1 | 2014 | 251 | 0.100 |
Why?
| | Selection, Genetic | 1 | 2011 | 23 | 0.100 |
Why?
| | DNA-Binding Proteins | 2 | 2012 | 424 | 0.100 |
Why?
| | Semen | 1 | 2011 | 21 | 0.090 |
Why?
| | Galectin 3 | 1 | 2011 | 14 | 0.090 |
Why?
| | Prostate-Specific Antigen | 1 | 2011 | 47 | 0.090 |
Why?
| | Binding Sites | 3 | 2009 | 375 | 0.090 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2010 | 41 | 0.090 |
Why?
| | RNA, Messenger | 2 | 2013 | 1097 | 0.080 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 96 | 0.080 |
Why?
| | Genetic Code | 1 | 2008 | 4 | 0.080 |
Why?
| | Dimerization | 2 | 2008 | 51 | 0.080 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2009 | 153 | 0.080 |
Why?
| | Genotype | 2 | 2013 | 542 | 0.080 |
Why?
| | Chromosome Breakage | 1 | 2008 | 16 | 0.080 |
Why?
| | Genome, Fungal | 1 | 2008 | 39 | 0.080 |
Why?
| | Gene Dosage | 1 | 2008 | 78 | 0.080 |
Why?
| | Activating Transcription Factors | 1 | 2008 | 9 | 0.080 |
Why?
| | Animals | 3 | 2011 | 13141 | 0.070 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 456 | 0.070 |
Why?
| | Transcription Factors | 2 | 2022 | 563 | 0.070 |
Why?
| | Molecular Sequence Data | 4 | 2010 | 795 | 0.070 |
Why?
| | DNA Damage | 1 | 2008 | 300 | 0.070 |
Why?
| | Protein Binding | 2 | 2005 | 655 | 0.070 |
Why?
| | Recombinases | 1 | 2005 | 9 | 0.060 |
Why?
| | Glycine | 1 | 2005 | 78 | 0.060 |
Why?
| | Tandem Repeat Sequences | 1 | 2004 | 7 | 0.060 |
Why?
| | Transformation, Genetic | 1 | 2004 | 17 | 0.060 |
Why?
| | Genes, Fungal | 1 | 2004 | 35 | 0.060 |
Why?
| | Spores, Fungal | 1 | 2004 | 20 | 0.060 |
Why?
| | Cell Separation | 1 | 2004 | 89 | 0.060 |
Why?
| | Cyclic AMP | 1 | 2004 | 92 | 0.060 |
Why?
| | Nitrogen | 1 | 2004 | 70 | 0.060 |
Why?
| | Transcriptional Activation | 1 | 2004 | 121 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 579 | 0.050 |
Why?
| | Amino Acid Sequence | 3 | 2010 | 576 | 0.050 |
Why?
| | Promoter Regions, Genetic | 1 | 2004 | 466 | 0.050 |
Why?
| | Microtubules | 1 | 2022 | 41 | 0.050 |
Why?
| | bcl-2-Associated X Protein | 1 | 2022 | 53 | 0.050 |
Why?
| | Caspase 3 | 1 | 2022 | 93 | 0.050 |
Why?
| | Flow Cytometry | 1 | 2004 | 475 | 0.050 |
Why?
| | Enzyme Activation | 1 | 2022 | 270 | 0.050 |
Why?
| | Cell Cycle | 1 | 2022 | 226 | 0.050 |
Why?
| | Humans | 4 | 2022 | 50201 | 0.040 |
Why?
| | Genetic Loci | 1 | 2019 | 44 | 0.040 |
Why?
| | Signal Transduction | 1 | 2004 | 1612 | 0.040 |
Why?
| | Fungal Proteins | 1 | 2018 | 124 | 0.040 |
Why?
| | Proteome | 1 | 2018 | 153 | 0.040 |
Why?
| | Phenotype | 1 | 2019 | 732 | 0.030 |
Why?
| | Protein Structure, Tertiary | 2 | 2008 | 249 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2019 | 1195 | 0.030 |
Why?
| | Codon, Terminator | 1 | 2014 | 8 | 0.030 |
Why?
| | Prions | 1 | 2014 | 7 | 0.030 |
Why?
| | Nucleic Acid Conformation | 1 | 2013 | 85 | 0.030 |
Why?
| | Guinea Pigs | 1 | 2011 | 75 | 0.020 |
Why?
| | Sequence Analysis, Protein | 1 | 2011 | 19 | 0.020 |
Why?
| | Chelating Agents | 1 | 2011 | 28 | 0.020 |
Why?
| | Gene Conversion | 1 | 2010 | 3 | 0.020 |
Why?
| | Immunoblotting | 1 | 2011 | 116 | 0.020 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2010 | 16 | 0.020 |
Why?
| | Protease Inhibitors | 1 | 2011 | 58 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2010 | 96 | 0.020 |
Why?
| | Archaeal Proteins | 1 | 2010 | 15 | 0.020 |
Why?
| | Zinc | 1 | 2011 | 53 | 0.020 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2010 | 66 | 0.020 |
Why?
| | Homeostasis | 1 | 2010 | 203 | 0.020 |
Why?
| | Osmotic Pressure | 1 | 2008 | 11 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2008 | 57 | 0.020 |
Why?
| | Conserved Sequence | 1 | 2008 | 56 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2009 | 174 | 0.020 |
Why?
| | Mutagenesis | 1 | 2008 | 60 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2008 | 145 | 0.020 |
Why?
| | Phosphorylation | 1 | 2009 | 525 | 0.020 |
Why?
| | Models, Biological | 1 | 2009 | 722 | 0.020 |
Why?
| | Crossing Over, Genetic | 1 | 2005 | 8 | 0.020 |
Why?
| | Chromatography, Gel | 1 | 2004 | 39 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2005 | 104 | 0.020 |
Why?
| | Protein Folding | 1 | 2004 | 48 | 0.010 |
Why?
| | Escherichia coli | 1 | 2004 | 191 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2004 | 480 | 0.010 |
Why?
| | Time Factors | 1 | 2005 | 2909 | 0.010 |
Why?
| | Male | 1 | 2011 | 25572 | 0.010 |
Why?
| | Female | 1 | 2011 | 26829 | 0.010 |
Why?
|
|
Davidson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|